In the US, Neupogen (filgrastim systemic) is a member of the drug class colony stimulating factors and is used to treat Bone Marrow Transplantation, Neutropenia, Neutropenia Associated with Chemotherapy, Neutropenia Associated with Radiation and Peripheral Progenitor Cell Transplantation.
- NEUPOGEN 30 MU (0.3MG/ML) SOLUTION FOR INJECTION (Leaflet)
- NEUPOGEN SINGLEJECT 30MU(0.6MG/ML)SOLUTION FOR INJECTION (Leaflet)
- NEUPOGEN SINGLEJECT 48MU (0.96MG/ML) (Leaflet)
Ingredient matches for Neupogen
Filgrastim is reported as an ingredient of Neupogen in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- New Zealand
- South Africa
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.